Visomitin (SKQ1) 是一种新型的线粒体（mitochondrial）靶向抗氧化剂，有望用于治疗与干眼病 (DED) 和角膜伤口等眼表疾病相关的炎症。SkQ1 在 HCjE cells上显示 317 nM 的 TC50。 Product introduction： Visomitin is a new antioxidant with the highest mitochondrion membrane penetrating ability and potent antioxidant capability. Direct treatment of tumor infiltrating leukocytes with Visomitin (SkQ1) does not influence their cytotoxicity against Panc02 cells. While Visomitin does not affect viability of the cell lines, this drug at 500 nM concentration reduces heavily the proliferation of human PDAC cells.